Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
AJNR. American Journal of Neuroradiology|April 13, 2013
Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 yearsR Zivadinov, N Bergsland, O Dolezal, et al.European Journal of Neurology|November 23, 2016
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approachT Uher, M Vaneckova, M P Sormani, et al.BMJ Open|November 17, 2020
A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementiaLucy Vivash, Charles B Malpas, Leonid Churilov, et al.Journal of Neurology|November 8, 2025
Big multiple sclerosis data network: novel modelling approaches for real-world data analysisM Trojano, P Iaffaldano, M Copetti, et al.Multiple Sclerosis and Related Disorders|February 26, 2022
Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint studyG Saposnik, S Andhavarapu, Ó Fernández, et al.European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.Journal of Medical Economics|December 12, 2023
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United KingdomT Spelman, W L Herring, C Acosta, et al.BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.Pageof 2